Premarketing Risk Assessment: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 29, 2005
January 31, 2025
232a7962-0cba-49be-a6b4-356c35b5f91f
Related Documents
E2E Pharmacovigilance Planning
Guidance DocumentApril 1, 2005Center for Drug Evaluation and Research
Q1E Evaluation of Stability Data
Guidance DocumentJune 8, 2004Center for Drug Evaluation and Research
Development and Use of Risk Minimization Action Plans: Guidance for Industry
Guidance DocumentMarch 29, 2005Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox